Table 1.
Stage | Finding(s) |
---|---|
I* | Tumor confined to the corpus uteri |
IA* | No invasion or invasion of less than half of the myometrium |
IB* | Invasion of half or more than half of the myometrium |
II* | Tumor invading the cervical stroma but not extending beyond the uterus† |
III* | Local and/or regional spread of the tumor |
IIIA* | Tumor invading the serosa of the corpus uteri and/or adnexa‡ |
IIIB* | Vaginal and/or parametrial involvement‡ |
IIIC* | Metastases to pelvic and/or para-aortic lymph nodes‡ |
IIIC1* | Positive pelvic lymph nodes |
IIIC2* | Positive para-aortic lymph nodes with or without positive pelvic lymph nodes |
IV* | Tumor invading the bladder and/or bowel mucosa, with or with-out distant metastases |
IVA* | Tumor invading the bladder and/or bowel mucosa |
IVB* | Distant metastases, including intra-abdominal metastases and/ or inguinal lymph nodes |
G1, G2, or G3.
Endocervical glandular involvement only should now be considered indicative of stage I rather than stage II.
Positive cytology should be reported separately and does not alter the stage.